Clinical Trials Browser

Withdrawn × Neoplasm Metastasis × pembrolizumab × Clear all

NCT06395090 2025-04-08

MK-9999-01B

Phase 1/2 Withdrawn

Neoplasm Metastasis

NCT03841747 2024-03-12

PELICAN

Phase 2 Withdrawn

Breast Neoplasms, Neoplasm Metastasis